4//SEC Filing
Dunsire Deborah 4
Accession 0001209191-22-039561
CIK 0001515673other
Filed
Jun 27, 8:00 PM ET
Accepted
Jun 28, 1:48 PM ET
Size
7.1 KB
Accession
0001209191-22-039561
Insider Transaction Report
Form 4
Dunsire Deborah
Director
Transactions
- Award
Common Stock
2022-06-24+3,300→ 15,870 total - Award
Stock Option (Right to Buy)
2022-06-24+6,245→ 6,245 totalExercise: $60.57Exp: 2032-06-24→ Common Stock (6,245 underlying)
Footnotes (2)
- [F1]Award of Restricted Stock Units ("RSUs") under the Company's 2014 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 24, 2023.
- [F2]The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 24, 2023.
Documents
Issuer
Ultragenyx Pharmaceutical Inc.
CIK 0001515673
Entity typeother
Related Parties
1- filerCIK 0001332764
Filing Metadata
- Form type
- 4
- Filed
- Jun 27, 8:00 PM ET
- Accepted
- Jun 28, 1:48 PM ET
- Size
- 7.1 KB